The Australasian Railway Association (ARA) is asking the government to consider modal equality under the proposed Emissions Reduction Fund (ERF) scheme. CEO of the ARA Bryan Nye said there were considerable synergies between the intent of ...
Belgium-based biopharmaceutical firm ThromboGenics has announced that its partner Alcon has launched Jetrea (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA) in Canada. According to the company, Canada is the ...
Tags: Alcon, Vitreomacular Adhesion
Inovio Pharmaceuticals has announced that preclinical testing of a DNA synthetic vaccine for the virulent Middle East Respiratory Syndrome coronavirus (MERS) induced robust and durable immune responses, demonstrating the potential for a ...
Tags: DNA Vaccine, MERS Virus
Covalon Technologies, an advanced medical technologies company, will showcase new wound healing and infection management products at MEDICA medical technology trade fair, 20 November to 23 November in Dusseldorf, Germany. The latest ...
Tags: Covalon, Wound Healing Products
Mauna Kea Technologies, the maker of Cellvizio, has announced the granting of the CE Mark and the pre-launch of a comprehensive range of probes aimed at endourological applications, to coincide with its first participation in the 107th ...
US-based Moderna Therapeutics has announced the completion of a new financing round, raising $110m to develop messenger RNA Therapeutics. In aggregate, Moderna has secured more than $415m in financing and partnerships to date from the ...
Pfizer has secured regular approval from the US Food and Drug Administration (FDA) for its Xalkori (crizotinib) capsules to treat patients with metastatic ALK-positive non-small cell lung cancer (NSCLC). The approval was based on ...
US-based Boston Scientific has obtained CE Mark approval for its Vercise deep brain stimulation (DBS) system for the treatment of intractable primary and secondary dystonia. Dystonia is a neurological movement disorder characterized by ...
Tags: Dystonia Treatment, DBS System
The Perstorp Group iis increasing its investment in the North East Asia Region. Considerable investments have already been made into a new Neopentyl Glycol plant at Zibo, in China, as well as increasing sales, market development and ...
The US Food and Drug Administration (FDA) has approved Janssen Therapeutics' NS3/4A protease inhibitor 'Olysio (simeprevir)' for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with ...
Produced Water Absorbents, Inc. and its subsidiaries (PWA) have completed a $9.2 million acquisition of the operating assets of oil and gas technology company ProSep Inc. and are launching a combined portfolio of patented solutions to treat ...
Tags: PWA, complete, acquisition, ProSep
Recently, Changyi Petrochemical performed an internal audit on its quality management system to examine its effectiveness and find opportunities for improvement. The audit involved all production and sales departments and processes ...
Tags: Changyi, petrochemical, quality management, audit
A new technology based on fish skin can be used to heal human skin wounds. This week, Kerecis Limited announced that it received FDA 510(k) clearance for a fish skin-based tissue regeneration technology. The technology is designed for the ...
Tags: Tissue Regeneration Technique, FDA
Israeli device manufacturer ITGI Medical announced a new partnership with Vascular Solutions. Under the new agreement, both companies will work together to land a Humanitarian Device Exemption (HDE) from FDA regulators for the ITGI ...
US-based Iroko Pharmaceuticals has entered into a $75m debt facility agreement with an affiliate of OrbiMed Advisors (OrbiMed) to support general business operations and the launch of Zorvolex (diclofenac). Zorvolex is the first and only ...